Seeking Alpha

Aeterna Zentaris (AEZS +16%) and Keryx Biopharmaceuticals (KERX +18.6%) shares soar on a bullish...

Aeterna Zentaris (AEZS +16%) and Keryx Biopharmaceuticals (KERX +18.6%) shares soar on a bullish analysis by Jeremy Richards in SA. Phase 3 clinical information is expected within two weeks on their top pipeline drug Perifosine; Richards believes the data is positive and the market has not realized the potential for the two companies.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|